Orchestra BioMed market cap OBIO
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Nov 2, 2026
- $342M
- Highest close in our data
- $607.8M
- May 2023
Orchestra BioMed is worth $342M at the close on Nov 2, 2026, at $5.69 a share.
That is up 66% over the last year and up 70% over five years.
Its highest close in our data was $607.8M in May 2023.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $342M | $197.1M | $367.8M | +40% |
| 2025 | $243.9M | $93.5M | $300.4M | +46% |
| 2024 | $167.3M | $157.1M | $311.7M | −49% |
| 2023 | $326.3M | $99.7M | $607.8M | +192% |
| 2022 | $111.9M | $110.2M | $204.9M | −46% |
| 2021 | $206.1M | $200.2M | $293.9M | −21% |
| 2020 | $262M | $222.9M | $262M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Orchestra BioMed's size, closest first, today.
| Company | Market cap |
|---|---|
| OBIOOrchestra BioMed | $342M |
| EMBCEmbecta | $350.7M |
| INFUInfuSystem | $275.7M |
| TCMDTactile Systems Technology | $518.1M |
| UTMDUtah Medical Products | $224.6M |
| PDEXPro DEX | $184.5M |
| MOVMovado | $710.9M |
| IRMDIradimed | $1B |
| IARTIntegra Lifesciences | $1.1B |
| BVSBioventus | $1.1B |
| KEQUKewaunee Scientific | $96.7M |
| Peer median | $434.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Orchestra BioMed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.